On May 8, 2025, Imunon, Inc. (NASDAQ:IMNN) announced that the first trial site for the Phase 3 OVATION 3 trial has been activated and is ready to begin enrolling patients. During the quarterly ...

Atea Pharmaceuticals announced the ongoing enrollment in its Phase 3 C-BEYOND trial evaluating the ... Kirsch was appointed to the Company’s Board of Directors. Mr. Kirsch has extensive ...

Python 3.14 has a new feature called the template string, or t-string, type. A t-string superficially resembles an f-string, but it’s designed to do something very different. Instead of just ...

Amid speculation that Chicago Mayor Brandon Johnson plans to appoint one of his top deputies to lead the Chicago Transit Authority, three CTA board members said Wednesday that they support a ...

The school board of the Easton Area School District heard ... The budget now includes a tax increase of 3.5%, raising the rate to 72.17 mills from the current 69.73 mills. Trent pointed out ...

GSK to pay $1.2 billion upfront and up to $800 million in milestones for efimosfermin, a Phase 3-ready liver disease drug. Efimosfermin showed fibrosis improvement, MASH resolution, and HbA1c ...

ISLAMABAD: The government’s second-phase auction for three dysfunctional or closed thermal power plants received a lukewarm response, with only one party submitting a bid — for the Jamshoro ...

The agreement announced Wednesday brings GSK efimosfermin alfa, a Boston Pharmaceuticals drug that is ready for Phase 3 testing. In addition to metabolic dysfunction-associated steatohepatitis ...

FRANKFURT, May 26 (Reuters) - Swiss drugmaker Roche (ROG.S), opens new tab said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious ...